Advances in high-resolution MS and hepatocyte models solve a long-standing metabolism challenge: the loratadine story.

Article Details

Citation

Aratyn-Schaus Y, Ramanathan R

Advances in high-resolution MS and hepatocyte models solve a long-standing metabolism challenge: the loratadine story.

Bioanalysis. 2016 Aug;8(16):1645-62. doi: 10.4155/bio-2016-0094. Epub 2016 Jul 27.

PubMed ID
27460981 [ View in PubMed
]
Abstract

BACKGROUND: Loratadine (LOR, Claritin((R))) is a long-acting antihistamine used to treat allergic rhinitis. The major active human metabolite, desloratadine (DL, Clarinex((R))), is extensively metabolized to 3-hydroxydesloratadine (3-OH-DL) (M40) and subsequently glucuronidated before elimination. This study revealed the ability of a novel, long-term hepatocyte micropatterned co-culture (MPCC) model to generate in vivo metabolites. Metabolites were detected and characterized using non-targeted MS/MS(ALL) with SWATH acquisition by a UHPLC-Q-TOF system. Results & methodology: Human MPCCs extensively metabolized LOR and formed 3-OH-DL-glucuronide (M13). Cross-species comparisons revealed monkey- and rat-specific metabolites with gender-specific DL-pyridine-N-oxide formation in male rats. These results demonstrate a first for an in vitro hepatocyte model to generate circulating metabolites of LOR and detect species-specific differences. Early focus on human metabolites could have spared characterization of nonhuman metabolites in preclinical species.

DrugBank Data that Cites this Article

Drugs
Drug Enzymes
DrugEnzymeKindOrganismPharmacological ActionActions
LoratadineCytochrome P450 1A1ProteinHumans
No
Substrate
Details
LoratadineCytochrome P450 2C19ProteinHumans
No
Substrate
Inhibitor
Details
LoratadineUDP-glucuronosyltransferase 1-1ProteinHumans
Unknown
Not AvailableDetails
LoratadineUDP-glucuronosyltransferase 1-3ProteinHumans
Unknown
Not AvailableDetails
LoratadineUDP-glucuronosyltransferase 2B15ProteinHumans
Unknown
Not AvailableDetails
Drug Reactions
Reaction
Details
Details